(Q35226280)

English

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

John B Ammori

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Lisa M Colletti

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mark M Zalupski

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Frederic E Eckhauser

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Joel K Greenson

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Justin Dimick

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Theodore S Lawrence

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Cornelius J McGinn

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

766-772

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality therapy for stage II and stage III pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN practice guidelines for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/13129554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1091-255X(03)00113-6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35226280&oldid=2197372130"